Champlain Investment Partners, LLC

Position in CAI — Caris Life Sciences, Inc.

CIK 1315478 BURLINGTON, VT

Position in CAI

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$18,690,720

-$2,907,658 QoQ

Shares Held

1,048,862

-13.2% QoQ

Ownership

0.371%

of shares outstanding

% of Portfolio

0.48%

of 13F equity value

Holder Rank

#30

of 246 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 94% Shared 0% None 6%

Healthcare · as of Jun 30, 2026

Champlain Investment Partners, LLC holds $83,031,252 across 3 Biotechnology names. CAI ranks #3 (22.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VCEL	Vericel Corp	755,828	$33,626,787
2	TECH	BIO-TECHNE Corp	434,731	$30,713,745
3	CAI	Caris Life Sciences, Inc. This page	1,048,862	$18,690,720

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$18,690,720	1,048,862	-13.2%	Shares	Sole	2026-08-12
2026-03-31	$21,598,378	1,207,963	+28.6%	Shares	Sole	2026-05-13
2025-12-31	$25,344,067	939,365	—	Shares	Sole	2026-02-13
No filing history on record for this holder in this stock.